Blackmer-Raynolds et al. identify microbiome-dependent transcriptional signatures across all major neural cell types, including bacteria-specific responses within brain-resident myeloid cells. Escherichia coli colonization triggers adaptive neuroimmune activation and modulates neurodegenerative disease pathways in wild-type mice, translating to exacerbated disease outcomes in a mouse model of Alzheimer’s disease.